Clinical trial · Interventional
Diagnostic Value of Ultralow-dose Computed Tomography for the Detection of Pulmonary Nodules and Lung Parenchym Alterations Compared to Standard-dose CT
NCT02468609CI-TRIAL-00020681RADFLunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To investigate the diagnostic value of ultralow-dose computed tomography in the detection of pulmonary nodules and lung parenchym alterations (e.g. emphysema) compared to standard-dose-CT.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Pulmonary Nodules | — | UNRESOLVED | — |
| Pulmonary Emphysema | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ultralow-Dose-CT | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Ultralow-Dose-CT
- description
- Additional Ultralow-Dose-CT of the chest
- interventionNames
- Radiation: Ultralow-Dose-CT
Primary outcomes (1)
- measure
- Number of pulmonary Nodules detected in the Ultralow-Dose thoracic CT
- timeFrame
- Participants CT-scan will be read out on an average date of 6 weeks after the scan
- description
- Difference in nodule detectability in Ultralow-Dose-CT compared to Standard-Dose-CT measured using McNemar test
Secondary outcomes (2)
- measure
- Patients BMI (Body mass index)
- timeFrame
- Measures assessed at time of read-out on an average date of 6 weeks after the scan
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * planned normal dose-CT by clinical indication at our institution * obtained informed consent Exclusion Criteria: * planned lowdose-CT by clinical indication at institution * no informed consent obtained * age \< 18 years * pregnancy
References
Publications (0)
Data not yet available
No reference posted for this study.